Clinical Trial Update: Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HEPLISAV vaccine to Engerix-B for hepatitis B; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HEPLISAV (hepatitis B vaccine)

Snippet

Sponsor: Dynavax Technologies Corporation | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2018-02-13